Relevium Technologies Inc.
TSX VENTURE : RLV
FRANKFURT : 6BX

Relevium Technologies Inc.

November 08, 2016 08:00 ET

Relevium Appoints Advisory Board

MONTREAL, QUEBEC--(Marketwired - Nov. 8, 2016) - Relevium Technologies Inc. (TSX VENTURE:RLV) and (FRANKFURT:6BX) (the "Company" or "Relevium") is pleased to announce the appointment of Martin M. Scullion and Quinn Roukema to the Advisory Board of the Corporation.

Mr. Martin M. Scullion, managing partner at the Southbank Healthcare Centre in Ottawa, is an experienced healthcare executive with extensive involvement in delivering and consolidating health services and medical clinics. Mr. Scullion's experience includes partnering with the Canadian Government and the European Bank of Reconstruction to provide special services to Bel Medic Hospital in Serbia. Mr. Scullion was also a senior executive at MED-EMERG International, a NASDAQ listed company and was responsible for the integration of YFMC Healthcare and its network of primary and immediate health care facilities. Mr. Scullion will provide guidance and assistance to Relevium Wellness Inc. in the strategic deployment and integration of Physio and Wellness clinics.

Mr. Quinn Roukema is an experienced entrepreneur with a focus on E-Commerce. Roukema began his career as brand manager for Red Bull in the Netherlands and moved to Montreal where he co-founded whopaid.it, a company that was subsequently sold to a venture firm in Texas. Mr. Roukema is currently co-founder and CEO of E-Retail Society Group (eretailsociety.com), which is a fast-growing global e-commerce. Mr. Roukema is a graduate of the Business & Innovation program from the VU University of Amsterdam. Mr. Roukema will assume the role advisor to Relevium E-Health Inc. and provide guidance over the Company's consolidation and strategic development of its E-Commerce business.

The advisory board is expected to meet and to work closely with management in providing guidance and support in the planning and execution of the company's business strategy.

Aurelio Useche, President and CEO stated: "On behalf our Board members and the management team, we are very pleased to welcome Mr. Scullion and Mr. Roukema to our Advisory Board. We believe that their unique expertise and business acumen will provide valuable contributions to the success of our company. We certainly look forward to working and integrating them to our team"

About Relevium Technologies Inc.

Relevium is a TSXV listed company focused on growth through the acquisition of businesses, products and/or technologies within the scope of the expanding health and wellness sector, specifically under three important verticals: Pain Relief, Recovery and Performance. Relevium Technologies Inc. currently holds patented intellectual property for application of static magnetic fields on direct-to-consumer devices, which aid in decreasing pain, improving recovery time and enhancing overall physical performance.

On Behalf of the Board of Directors

RELEVIUM TECHNOLOGIES INC.

"Aurelio Useche", CEO and Director

NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain "forward-looking statements" under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to the business and operations of the Company. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; delay or failure to receive board, shareholder or regulatory approvals; and the ability of the Company to secure adequate funding in order to execute and achieve its business objectives. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. There can be no assurance that the conditions to the transactions contemplated by the potential letter of intents will be satisfied or that those transactions will be completed. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Contact Information